<!doctype html public "-//w3c//dtd html 4.0 transitional//en">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<meta name="Content-Type" content="text/html; charset=iso-8859-1" />
<meta name="description" content="Interactive Introductory / Foundational Evolution and Molecular Biology" />
<meta name="" content="ffree on-line biology, molecular biology, text" />
<meta name="GENERATOR" content="Mozilla/4.75 (Macintosh; U; PPC) [Netscape]" />
<title>Biofundamentals @ UC Boulder- Protein folding and turnover</title>
<script language="JavaScript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}
//-->
</script>
</head>
<style type="text/css">
<!--
a:link {
	text-decoration: none
}
a:visited {
	text-decoration: none
}
a:active {
	text-decoration: none
}
a:hover {
	text-decoration: underline
}
.style1 {
	font-family: Arial, Helvetica, sans-serif;
	font-size: x-small;
}
.style2 {
	font-family: Arial, Helvetica, sans-serif
}
.style3 {
	color: #990000;
	font-weight: bold;
}
body, td, th {
	font-family: Arial, Helvetica, sans-serif;
}
.style4 {
	font-size: x-small
}
.white {
	color: #FFF;
}
-->
</style>
<body text="#000000" bgcolor="#FCFDFF" link="#0000FF" vlink="#0066FF" alink="#0066FF" onLoad="MM_preloadImages('../../../Biofundamentals/Biofundamentals/lectureNotes/graphics/week5graphics/prpsc.gif')">
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
        <td width="667"><b><font face="Arial, Helvetica, sans-serif" color="#000000">24.
                    Assembling 
            &amp; disassembling proteins <a name="top"></a></font></b></td>
        <td width="24"><a href="Topic3-6_Making Proteins.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowLEFT.GIF" alt="" width="24" height="24" border="0" /></a></td>
        <td width="29"><div align="right"><a href="Topic3-8_Protein Activity.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowRIGHT.gif" alt="arrow" width="24" height="24" border="0" /></a></div></td>
        <table width="700" border="0" cellpadding="0" cellspacing="0">
            <tr>
                <td><hr size="1" noshade /></td>
            </tr>
        </table>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">New amino acids are
      added to the polypeptide's C-terminus, while the N-terminus
      moves through a tunnel within the ribosome; about 15 amino
      acids are added per second. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">The ribosomal tunnel
        is approximately 10 nm long and 1.5 nm in diameter; it is
        narrow enough to block the folding of the newly synthesized
        polypeptide chain. </font></p></td>
    <td>&nbsp;</td>
    <td><img src="../../../Biofundamentals/BioFun-Support/wordles/page20.jpg" width="320" height="160" alt="page 19" /></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p>Translation, like most all processes that occur within the cell,
      is a <a href="http://en.wikipedia.org/wiki/Stochastic" target="_blank">stochastic</a> process,
      meaning that it is based on random collisions between molecules.
      In the specific case of translation, the association of the mRNA
      with the ribosomal components occurs stochastically; similarly,
      the addition of a new amino acid depends on the collision of
      the appropriate amino acid-charged, tRNAs with the RNA-ribosome
      complex. </p>
      <p>Since there are many &quot;inappropriate&quot; amino-acid charged
        tRNAs in the cytoplasm, the ribosomal complex must be able to
        productively bind only the tRNA the mRNA specifies, that is the
        tRNA with the right anticodon.&nbsp; This enables its attached
        amino acid can interact productively to add the amino acid to
        the growing polypeptide chain. </p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="22%"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/peptidePath.gif" alt="peptide" width="153" height="164" /></td>
    <td width="1%" bgcolor="#FFFFFF">&nbsp;</td>
    <td width="77%"><p><font face="Arial, Helvetica, sans-serif">In most
      illustrations of polypeptide synthesis, you rarely see this
      fact illustrated. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">As the polypeptide emerges
        from the tunnel, it encounters the crowded cytoplasmic environment;
        at the same time it begins </font><font face="Arial, Helvetica, sans-serif"> to
          fold.&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">As it folds, the polypeptide
        needs to avoid non-specific interactions with other cellular
        components. If it is part of a multisubunit protein, it must &quot;find&quot; its
        partner polypeptides, again, a stochastic process.</font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><iframe width="720" height="406" src="http://www.youtube.com/embed/i8rGTYQ6oZ8" frameborder="0" allowfullscreen></iframe></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="578"><p><font face="Arial, Helvetica, sans-serif">If the polypeptide
      does not fold correctly, it will not function correctly and
      may damage the cell. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">A number of degenerative
        neurological disorders are due, at least in part, to the
        accumulation of misfolded polypeptides (see below). </font></p>
      <p><font face="Arial, Helvetica, sans-serif">A number of enzymes,
        known generically as chaperones, associate with the nascent
        polypeptide as it emerges from the ribosome. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Chaperones facilitate
        the proper folding of the polypeptide, primarily by suppressing
        or unfolding 'incorrect' structures (perhaps you can guess
        how a chaperone &quot;knows&quot; something bad is going
        on).</font></p>
      <p><font face="Arial, Helvetica, sans-serif">Chaperones bind to,
        and stabilize polypeptides prior to their final assembly
        into multisubunit complexes, the final active protein</font></p></td>
    <td width="10" bgcolor="#FFFFFF">&nbsp;</td>
    <td width="114"><div align="right"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ChaperoneNascentPolypeptide.jpg" alt="chap" width="113" height="300" /></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="362"><iframe width="358" height="260" src="http://www.youtube.com/embed/swEc_sUVz5I?rel=0" frameborder="0" allowfullscreen></iframe></td>
    <td width="339">&nbsp;</td>
    <td width="19"><iframe width="358" height="260" src="http://www.youtube.com/embed/gFcp2Xpd29I?rel=0" frameborder="0" allowfullscreen></iframe></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="80"><p><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/RefoldingChaperone.jpg" alt="refolding" width="80" height="260" /></p></td>
    <td width="14" bgcolor="#FFFFFF">&nbsp;</td>
    <td width="566"><div align="right">
      <p align="left"><font face="Arial, Helvetica, sans-serif">One
        class of chaperones are known as heat shock proteins. </font></p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">These
        proteins recognize unfolded polypeptides &ndash; protein
        unfolding occurs with increasing frequency at higher
        temperatures. </font></p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">Heat-shock
        chaperones couple ATP hydrolysis reactions with polypeptide
        unfolding reactions to unfold misfolded polypeptides.&nbsp; They
        then release the unfolded polypeptide or protein, giving
        it another chance to refold correctly, on its own.&nbsp;</font></p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">How
        do chaperones recognize unfolded or abnormally folded
        proteins? They look for hydrophobic regions on their
        surface. </font></p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">Normal
        soluble proteins do not have such regions and the presence
        of such domains can lead to non-specific protein-protein
        aggregates. </font></p>
    </div></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><iframe width="720" height="540" src="http://www.youtube.com/embed/b39698t750c" frameborder="0" allowfullscreen></iframe></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif"><strong>Protein degradation:&nbsp; </strong></font></p>
      <p><font face="Arial, Helvetica, sans-serif">If
        a protein does not fold correctly, it is generally degraded
        by enzymes known as proteases, enzymes that cleave proteins.
        This involves forming a complex with the protease.</font>&nbsp;<font face="Arial, Helvetica, sans-serif">Proteases
          cleave peptide bonds via a hydrolysis reaction.</font> The
        hydrolysis of a protein is a thermodynamically favorable
        reaction.&nbsp; </p>
      <p>It is the case that proteins differ in the probability that they
        will form a productive complex with a <font face="Arial, Helvetica, sans-serif">protease.
          In</font> this case, a productive interaction means that the
        protein will be degraded.           &nbsp;<font face="Arial, Helvetica, sans-serif">The
          process of degradation is known as turnover, in part because
          the amino acids released can be reused by the cell. </font></p>
      <p>The end result of the processes of translation (protein synthesis),
        folding, and degradation is that each protein in a cell has a
        half-life. If we had a population of molecules, the half-life
        is the time at which we would expect 50% of the those molecules <font face="Arial, Helvetica, sans-serif">present
          at time = 0 to have been degraded through interactions with proteases.&nbsp; </font></p>
      <p><font face="Arial, Helvetica, sans-serif">There are a number of
        mechanisms involved in the turnover of proteins. </font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="401"><div align="right"><a href="http://www.biocarta.com/pathfiles/proteasomePathway.asp" target="_blank"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/proteosome.jpg" alt="degradation" width="400" height="298" border="0" /></a></div></td>
    <td width="12">&nbsp;</td>
    <td width="287"><div align="right">
      <p align="left"><font face="Arial, Helvetica, sans-serif">A common
        one involves a macromolecular machine, the proteosome.</font></p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">The
        proteosome is a multienzyme complex that degrades polypeptides.
        The proteases can be divided into two generic classes. </font> <font face="Arial, Helvetica, sans-serif">Those
          that hydrolyze polypeptides from one end or the other,
          to release one or twp amino acid at a time, are known
          as exoproteases.&nbsp;</font></p>
      <p align="left">Please note (in the video below), the unrealistic
        components.</p>
    </div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><iframe width="720" height="540" src="http://www.youtube.com/embed/4DMqnfrzpKg" frameborder="0" allowfullscreen></iframe>
      <p align="left">&nbsp;</p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">Proteases that cleave
      a polypeptide chain internally are known as endoproteases
      - they generate two polypeptides.&nbsp; </font></p>
      <p>Whether a protein is degraded depends upon how it interacts with
        other molecules, particularly chaperones and proteosomes, and
        other proteases [a mathematical analysis of protein (and RNA)
        half-life is beyond the scope of this course, but you can read
        about it <a href="http://en.wikipedia.org/wiki/Protein_turnover">here</a> and <a href="http://www.ncbi.nlm.nih.gov/pubmed/15596551" target="_blank">here</a> if
        you wish.]</p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" noshade></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p align="left"><font face="Arial, Helvetica, sans-serif"><b>Diseases
      of folding and misfolding:</b><strong> </strong>If the
      functional protein is in its native state</font>, a dysfunctional
      misfolded protein is said to be denatured. </p>
      <p align="left"><font face="Arial, Helvetica, sans-serif">It does
        not take much of a perturbation to unfold or denature most
        proteins. In fact, under normal conditions, proteins often
        become partially denatured. A number of diseases have been
        associated with <a href="http://www.faseb.org/opar/protfold/protein.html" target="_blank">protein
          misfolding</a><b>. </b></font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="549"><p><font face="Arial, Helvetica, sans-serif">Kuru </font> was
      among the first of these to be identified. Beginning in the 1950s, <a href="http://www.xrefer.com/entry/494426" target="_blank">D.
        Carleton Gadjusek</a> studied a neurological disorder common
      among the Fore<strong> </strong>people of New Guinea.</p>
      <p><font face="Arial, Helvetica, sans-serif">The symptoms of <a href="http://www.xviral.co.uk/disease/kuru.htm" target="_blank">kuru</a>,
        which means &quot;trembling with fear&quot;, are similar
        to those of <a href="http://www.niddk.nih.gov/intram/people/wickner/prions.htm" target="_blank">scrapie</a>,
        a disease of sheep, and <a href="http://www.emedicine.com/med/topic1248.htm" target="_blank">variant
          Creutzfeld-Jakob disease</a> (vCJD) in humans. </font></p></td>
    <td width="10">&nbsp;</td>
    <td width="101"><div align="right"><a href="http://www.nobel.se/medicine/laureates/1976/gajdusek-lecture.html" target="_blank"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/gajdusek.jpg" alt="gadj" width="100" height="141" border="0" /></a></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">Among the Fore people,
      kuru was linked to the ritual eating of the dead. Since this
      practice has ended, the disease has disappeared.</font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="100"><a href="http://www.nobel.se/medicine/laureates/1997/illpres/" target="_blank"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/prusiner.jpg" alt="prusiner" width="100" height="141" border="0" /></a></td>
    <td width="10">&nbsp;</td>
    <td width="590"><p><font face="Arial, Helvetica, sans-serif"><strong>Prions
      and protein folding: </strong></font></p>
      <p><font face="Arial, Helvetica, sans-serif">The cause of kuru, scrapie
        and vCJD appears to be the presence of an abnormal form of
        a normal protein, known as a prion</font>. We can think of
        prions as an anti-chaperone.</p>
      <p><font face="Arial, Helvetica, sans-serif">The idea of proteins
        as infectious agents was championed by Stan Prusiner. </font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="557"><font face="Arial, Helvetica, sans-serif">The protein
      responsible for kuru and scrapie is known as PrP<sup>c</sup><strong><font color="#000000">.&nbsp; </font></strong></font>It
      normally exists in a largely &alpha;-helical form.&nbsp; There
      is a second abnormal form of the protein, PrP<sup>sc</sup> for
      scrapie; it is composed primarily of &beta;-sheet.&nbsp;</td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="415"><p><font face="Arial, Helvetica, sans-serif">The two
      polypeptides have the same primary sequence.&nbsp; <font color="#000000">PrP<sup>sc</sup></font> acts
      as an anti-chaperone, catalyzing the transformation of <font color="#000000">PrP<sup>c</sup></font> into <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font>.</font></p>
      <p><font face="Arial, Helvetica, sans-serif">Once initiated, this
        leads to a chain reaction</font> and <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font> accumulation. <font color="#000000" face="Arial, Helvetica, sans-serif"> As
          it accumulates, PrPsc assembles</font> into rod-shaped aggregates
        that appear to damage cells. </p></td>
    <td width="10">&nbsp;</td>
    <td width="277"><div align="right"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/prionForms.jpg" alt="prion form" width="276" height="189" /></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="360"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/prion.jpg" alt="prion" width="360" height="200" /></td>
    <td width="13" bgcolor="#FFFFFF">&nbsp;</td>
    <td width="347"><p><font face="Arial, Helvetica, sans-serif">This process
      occurs within the cells of the central nervous system, and
      leads to severe neurological defects.</font></p>
      <p><font face="Arial, Helvetica, sans-serif">There is no natural
        defense, since the protein responsible is a normal protein.</font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="528"><div align="right">
      <p align="left"><strong>Disease transmission:&nbsp;</strong>When
        the Fore ate the brains of their beloved ancestors, they
        inadvertently introduced the <font color="#000000">PrP<sup>sc</sup></font> protein
        into their bodies. </p>
      <p align="left">Genetic studies indicate that early humans evolved
        resistance to prion diseases, suggesting that cannibalism
        might have been an important selective factor during human
        evolution.<span class="style1">&nbsp;</span></p>
    </div></td>
    <td width="11">&nbsp;</td>
    <td width="181"><div align="right"><a href="http://news.nationalgeographic.com/news/2003/04/0410_030410_cannibal.html" target="_blank"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/NoseBone.jpg" alt="nose" width="180" height="120" border="0" /></a></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">Since cannibalism is
      not nearly as common today, how does anyone get such diseases
      in the modern world? </font></p>
      <p><font face="Arial, Helvetica, sans-serif">There are rare cases
        of iatrogenic</font> transmission, that is, where the disease
        is caused by <a href="http://www.iatrogenic.org/define.html" target="_blank">faulty
          medical practice</a>, for example through the use of contaminated
        surgical instruments or diseased tissue for transplantation. </p>
      <p><font face="Arial, Helvetica, sans-serif">Where did these people
        get the disease?&nbsp; Since the disease is caused by the
        formation of <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font>,
        any event that leads to <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font> formation
        could cause the disease. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Normally, the formation
        of <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font> from <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>c</sup></font><font color="#000000"> is</font> very
        rare. We all have <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>c</sup></font> but
        very few of us spontaneously develop kuru-like symptoms.&nbsp;</font><font face="Arial, Helvetica, sans-serif">There
          are, however, mutations in the <font color="#000000" face="Arial, Helvetica, sans-serif">gene
            that encodes PrP<sup>c </sup></font>that greatly enhance
          the frequency of the <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>c</sup></font> &rarr; <font color="#000000">PrPsc
            conversion.</font>&nbsp;</font></p></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="390"><p><font face="Arial, Helvetica, sans-serif">Such mutations
      may be inherited (genetic) or may occur during the life of
      an organism (sporadic). </font></p>
      <p align="right"><font face="Arial, Helvetica, sans-serif" class="style1">The
        schematic of the brain on the left is from<br />
        a person with <a href="http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?600072" target="_blank">familial
          fatal insomnia (FFI)</a>. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">FFI is due to the inheritance
        of a mutation in the <a href="http://www.ncbi.nlm.nih.gov:80/entrez/dispomim.cgi?id=176640" target="_blank">PRNP</a> gene;
        this mutation changes the normal aspartic acid 178 to an
        asparagine. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">The squares mark brain
        regions affected; the lower section reveals the presence
        of aberrant protein aggregates in these regions. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">When combined with a
        second mutation in the PRNP gene at position 129, the FFI
        mutation leads to <a href="http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?123400" target="_blank">Creutzfeld-Jacob
          disease (CJD)</a>. </font></p></td>
    <td width="10">&nbsp;</td>
    <td width="304"><div align="center"><font face="Arial, Helvetica, sans-serif"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/FFI_CJD brains.jpg" alt="brain" width="296" height="344" /></font></div></td>
  </tr>
</table>
<table width="700" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><p><font face="Arial, Helvetica, sans-serif">The circles in the right
      hand brain schematic indicate regions affected in CJD. There
      are holes or lacunae in the tissue.&nbsp; </font><font face="Arial, Helvetica, sans-serif">Both
        FFI and CJD are late onset diseases. Symptoms first appear
        ~ 50 years of age.</font></p></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td>&nbsp;</td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td width="480"><p><font face="Arial, Helvetica, sans-serif">So why do <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font> aggregates
      accumulate? </font></p>
      <p><font face="Arial, Helvetica, sans-serif">To cut a peptide bond,
        a protease must position the target peptide bond within its
        catalytic active site.</font><font face="Arial, Helvetica, sans-serif">If the target protein's
          peptide bonds do not fit into the active site, they cannot
          be cut. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">Because of their structure, <font color="#000000" face="Arial, Helvetica, sans-serif">PrP<sup>sc</sup></font> aggregates
        are highly resistant to proteolysis. </font></p>
      <p><font face="Arial, Helvetica, sans-serif">They gradually accumulate
        over many years, a fact that may explain the late onset of
        PrP-based diseases.</font></p></td>
    <td width="10">&nbsp;</td>
    <td width="231"><div align="right"><a href="http://www.biochem.emory.edu/labs/genekdw/protdeg2000/why.html" target="_blank"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/zincprotease.jpg" alt="zinc" width="230" height="200" border="0" /></a></div></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><div align="right">for the pre-medical students along you.</div></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><iframe width="720" height="540" src="http://www.youtube.com/embed/yzDQ8WgFB_U" frameborder="0" allowfullscreen></iframe></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
        <td><hr noshade /></td>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0" bgcolor="#CCCCCC">
  <tr>
    <td width="78" bgcolor="#990000"><div align="center">
      <p class="white">Questions to answer</p>
    </div></td>
    <td width="622" bgcolor="#FFFFFF"><font face="Arial, Helvetica, sans-serif">&nbsp; </font>
      <ol>
        <li>Why does the ribosome tunnel inhibit the folding of the newly
          synthesized polypeptide?</li>
        <li>How would you expect protein degradation to be controlled? </li>
        <li>How is the presence of a prion<sup>sc</sup> lead to the change
          in the structure of prion<sup>c</sup>, and is this necessarily
          a genetic change?&nbsp;</li>
        <li>Why is it, do you think, that FFI and CJD are late onset
          diseases?</li>
        <li>What, do you think, leads to the &quot;lacunae&quot; in brain tissue? </li>
      </ol></td>
  </tr>
  <tr>
    <td bgcolor="#0000FF"><div align="center"><span class="whoe1"><span class="white">Questions
      to ponder</span></span><br />
    </div></td>
    <td bgcolor="#FFFFFF"><ul>
      <li class="style21"><span class="style2">Why are proteins (and
        RNAs) degraded? </span></li>
      <li class="style21"><span class="style2">Which do you think would
        be more susceptible to proteolytic degradation, a compact
        or an extended polypeptide? </span></li>
    </ul></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
    <td><hr size="1" /></td>
  </tr>
</table>
<table width="720" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><iframe width="720" height="574" frameborder="0" src="http://besocratic.clemson.edu/besocratic.html?Activity=861#/ActivityViewerPage"></iframe></td>
  </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
  <tr>
        <td><hr size="1" /></td>
    </tr>
</table>
<table width="720" border="0" cellpadding="0" cellspacing="0">
    <tr>
        <td width="24"><a href="Topic3-6_Making Proteins.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowLEFT.GIF" alt="" width="24" height="24" border="0" /></a></td>
        <td width="29"><div align="left"><a href="#TOP"><font face="Arial, Helvetica, sans-serif" size="-2"> <img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowUP.GIF" width="24" height="24" /></font></a></div></td>
        <td width="637"><div align="right"><font size="-2" face="Arial, Helvetica, sans-serif"> revised
                <!-- #BeginDate format:En2 -->31-Aug-2012<!-- #EndDate -->
                </font></div></td>
        <td width="30"><div align="right"><a href="Topic3-8_Protein Activity.htm" target="_self"><img src="../../../Biofundamentals/BioFun-Support/AllGraphics/ArrowRIGHT.gif" width="24" height="24" border="0" /></a></div></td>
    </tr>
</table>
<script type='text/javascript'>var _hl=_hl||{};_hl.site='41';(function(){var hl=document.createElement('script');hl.type='text/javascript';hl.async=true;hl.src=document.location.protocol+'//highlighter.com/webscript/v1/js/highlighter.js';var s=document.getElementsByTagName('script')[0];s.parentNode.insertBefore(hl,s);})();</script>
</body>
</html>
